Annexon (ANNX) News Today

$4.87
+0.14 (+2.96%)
(As of 05/8/2024 ET)
SourceHeadline
globenewswire.com logoAnnexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting
globenewswire.com - May 7 at 12:30 PM
globenewswire.com logoAnnexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting
globenewswire.com - May 1 at 8:00 AM
marketbeat.com logoShort Interest in Annexon, Inc. (NASDAQ:ANNX) Grows By 15.3%
marketbeat.com - April 29 at 7:13 AM
marketbeat.com logoCantor Fitzgerald Reaffirms "Overweight" Rating for Annexon (NASDAQ:ANNX)
marketbeat.com - April 24 at 9:18 AM
morningstar.com logoAnnexon Inc Ordinary Shares
morningstar.com - April 20 at 12:43 AM
marketbeat.com logoVontobel Holding Ltd. Decreases Stock Position in Annexon, Inc. (NASDAQ:ANNX)
marketbeat.com - April 19 at 5:37 AM
finance.yahoo.com logoAre Medical Stocks Lagging Annexon (ANNX) This Year?
finance.yahoo.com - April 17 at 1:07 PM
finance.yahoo.com logoAre Medical Stocks Lagging Annexon (ANNX) This Year?
finance.yahoo.com - April 17 at 1:07 PM
globenewswire.com logoAnnexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - April 16 at 4:05 PM
marketbeat.com logoAnnexon (NASDAQ:ANNX) Shares Gap Down to $5.74
marketbeat.com - April 16 at 2:58 PM
marketbeat.com logoAnnexon (NASDAQ:ANNX) Trading Down 3.5%
marketbeat.com - April 15 at 1:55 PM
marketbeat.com logoAnnexon, Inc. (NASDAQ:ANNX) Short Interest Update
marketbeat.com - April 12 at 7:37 AM
markets.businessinsider.com logoBuy Rating on Annexon Biosciences: Promising Pipeline and Strategic Growth Potential
markets.businessinsider.com - April 11 at 1:22 PM
insidertrades.com logoInsider Buying: Annexon, Inc. (NASDAQ:ANNX) Director Buys 3,200 Shares of Stock
insidertrades.com - April 11 at 6:48 AM
marketbeat.com logoInsider Buying: Annexon, Inc. (NASDAQ:ANNX) Director Purchases 3,200 Shares of Stock
marketbeat.com - April 10 at 9:16 PM
marketbeat.com logoAnnexon (NASDAQ:ANNX) Shares Gap Down to $6.05
marketbeat.com - April 9 at 11:25 AM
marketbeat.com logoAnnexon (NASDAQ:ANNX) Shares Down 4.5%
marketbeat.com - April 8 at 11:59 AM
marketbeat.com logoAnnexon's (ANNX) "Overweight" Rating Reaffirmed at Cantor Fitzgerald
marketbeat.com - April 3 at 10:18 AM
globenewswire.com logoAnnexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
globenewswire.com - April 3 at 8:00 AM
markets.businessinsider.com logoAnalysts Are Bullish on Top Healthcare Stocks: Annexon Biosciences (ANNX), Insmed (INSM)
markets.businessinsider.com - April 1 at 3:14 PM
marketbeat.com logoAnnexon (NASDAQ:ANNX) PT Raised to $13.00 at JPMorgan Chase & Co.
marketbeat.com - April 1 at 10:37 AM
marketbeat.com logoFY2024 EPS Estimates for Annexon, Inc. Lifted by HC Wainwright (NASDAQ:ANNX)
marketbeat.com - March 29 at 8:38 AM
marketbeat.com logoAnnexon (NASDAQ:ANNX) Price Target Raised to $10.00 at Bank of America
marketbeat.com - March 28 at 2:35 PM
markets.businessinsider.com logoAnticipating Growth: Positive Outlook for Annexon Biosciences Amid Upcoming Clinical Trials and New Data Readouts
markets.businessinsider.com - March 28 at 12:47 PM
marketbeat.com logoHC Wainwright Comments on Annexon, Inc.'s Q1 2024 Earnings (NASDAQ:ANNX)
marketbeat.com - March 28 at 8:24 AM
finanznachrichten.de logoAnnexon Biosciences: Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones
finanznachrichten.de - March 27 at 10:27 AM
markets.businessinsider.com logoAnnexon Biosciences (ANNX) Receives a Buy from TD Cowen
markets.businessinsider.com - March 27 at 10:27 AM
marketbeat.com logoWells Fargo & Company Raises Annexon (NASDAQ:ANNX) Price Target to $12.00
marketbeat.com - March 27 at 9:10 AM
marketbeat.com logoAnnexon's (ANNX) "Buy" Rating Reiterated at HC Wainwright
marketbeat.com - March 27 at 9:10 AM
globenewswire.com logoAnnexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones
globenewswire.com - March 26 at 4:05 PM
globenewswire.com logoAnnexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - March 18 at 4:05 PM
ca.finance.yahoo.com logoANNX Jul 2024 7.500 put
ca.finance.yahoo.com - March 16 at 11:42 PM
ca.finance.yahoo.com logoANNX Apr 2024 2.500 call
ca.finance.yahoo.com - March 16 at 11:42 PM
finance.yahoo.com logoANNX Apr 2024 7.500 put
finance.yahoo.com - March 16 at 6:32 PM
finance.yahoo.com logoNational group to cut realtor commissions, make home-buying more affordable
finance.yahoo.com - March 16 at 8:31 AM
finance.yahoo.com logoCannabis Grower Ascend Seeks Private Loan to Refinance Debt
finance.yahoo.com - March 15 at 3:50 PM
seekingalpha.com logoHRTX, LUNA and ARQ among mid-day movers
seekingalpha.com - March 13 at 4:38 PM
marketbeat.com logo976,987 Shares in Annexon, Inc. (NASDAQ:ANNX) Purchased by Kennedy Capital Management LLC
marketbeat.com - March 10 at 6:53 AM
finance.yahoo.com logoANNX Mar 2024 10.000 put
finance.yahoo.com - March 7 at 1:27 PM
marketbeat.com logoAnnexon, Inc. Expected to Post FY2023 Earnings of ($1.70) Per Share (NASDAQ:ANNX)
marketbeat.com - March 7 at 6:40 AM
marketbeat.com logoAnnexon (NASDAQ:ANNX) Rating Reiterated by HC Wainwright
marketbeat.com - March 4 at 8:25 AM
marketbeat.com logoAnnexon, Inc. (NASDAQ:ANNX) Shares Sold by Federated Hermes Inc.
marketbeat.com - March 4 at 5:52 AM
marketbeat.com logoAnnexon (ANNX) to Release Earnings on Monday
marketbeat.com - March 3 at 7:31 AM
msn.com logoJP Morgan Upgrades Annexon (ANNX)
msn.com - March 2 at 8:35 AM
marketbeat.com logoAnnexon (NASDAQ:ANNX) Upgraded at JPMorgan Chase & Co.
marketbeat.com - March 1 at 7:41 AM
globenewswire.com logoAnnexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference
globenewswire.com - February 27 at 8:00 AM
benzinga.com logoAnnexon Stock (NASDAQ:ANNX), Short Interest Report
benzinga.com - February 22 at 1:24 PM
finance.yahoo.com logoAnnexon to Host Virtual R&D Day on Guillain-Barré Syndrome, Focusing on its Serious Unmet Need and Annexon’s Novel Therapeutic Approach
finance.yahoo.com - February 21 at 10:39 AM
globenewswire.com logoAnnexon to Host Virtual R&D Day on Guillain-Barré Syndrome, Focusing on its Serious Unmet Need and Annexon's Novel Therapeutic Approach
globenewswire.com - February 21 at 8:00 AM
globenewswire.com logoAnnexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - February 20 at 4:05 PM
Get Annexon News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter.

He Is Giving Away Bitcoin (Ad)

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

ANNX Media Mentions By Week

ANNX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ANNX
News Sentiment

0.00

0.36

Average
Medical
News Sentiment

ANNX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ANNX Articles
This Week

1

2

ANNX Articles
Average Week

Get Annexon News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ANNX) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners